VEGFA and neoplasm: Neutrophils significantly inhibit lymphokine-activated killer cell-mediated cytotoxic effects, thereby downregulating the patient's anti-tumour cellular immune response and neutrophils also release vascular endothelial growth factor (VEGF), a pro-angiogenic factor associated with promoting tumour formation, invasion and metastasis [31, 32].